Eosinophils, Asthma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma (NCT03052725) | Teva Branded Pharmaceutical Products R&D, Inc. | 2017-03-10 |
Track Eosinophils, Asthma automatically
Every clearance here is in the API, with alerts when new ones post.